•  
  •  
 

Abstract

ABSTRACT:BACKGROUND:Alopecia areata is an inflammatory, non-scaring type of hair loss. Microneedling is a new therapeutic procedure used in dermatology. It facilitates the absorption of topical therapies across the epidermis.AIM OF STUDY:Evaluating the efficacy of Microneedling combined with clobetasol propionate 0.05% cream versus clobetasol propionate 0.05% cream alone in treatment of alopecia areata.PATIENTS AND METHODS:This study was carried out on 20 patients and the total number of patches was 99. In the same patient,              at least 2 patches were selected to be treated as group A or B; so, the 99 patches were divided in to two groups.Group A: Microneedling combined with clobetasol propionate 0.05% cream: 51 patches (from 20 patients) were treated using a dermapen devise. The cream was applied before and after microneedling and a total of four sessions were done at 2 weeks interval, then patients were seen after 2 weeks from              the last session for follow up. Group B: clobetasol propionate 0.05% cream alone: 48 patches (from               the same 20 patients) were treated, the cream was applied twice daily with gentle massage for 3-5 minutes for 8 weeks duration. Patients were seen at 2 weeks interval.RESULTS:At 8th week visit: the response to treatment in group A was seen in 58.8% of the patches and 63.3% of them showed complete coarse hair regrowth while in group B, the response to treatment was seen in 58.3% of the patches and 32.1% of them showed complete coarse hair regrowth. When two groups were compared regarding complete hair regrowth there was statistically significant difference.CONCLUSION:Combination of Microneedling with clobetasol propionate 0.05% cream is a promising, safe and easy to perform technique in the treatment of alopecia areata  

DOI

10.52573/ipmj.2023.180585

Download

Share

COinS